Anogen Life Sciences
St. Petersburg, US · Founded 2017 · Delaware corporation
Founders & leadership
SB
Steven B. BettisNamed on SEC filing
AR
Andreas ReiffNamed on SEC filing
DA
David AdairNamed on SEC filing
SY
Seth YakatanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$407.6K disclosed across 1 round · 2021
▶$407.6KraisedFeb 2021 · 12 investors · BiotechnologyRule 506(b)
▶$407.6KraisedFeb 2021 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven B. BettisExecutive Officer, Director
- Andreas ReiffDirector
- David AdairDirector
- Seth YakatanDirector
- Offering amount
- $407.6K
- Amount sold
- $407.6K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Anogen Life Sciences raised?
- Anogen Life Sciences has disclosed $407.6K raised across 1 round.
- Where is Anogen Life Sciences headquartered?
- Anogen Life Sciences is headquartered in St. Petersburg, US.